Surmodics (SRDX) announced the successful early clinical use of its Pounce XL Thrombectomy System. The Pounce XL Thrombectomy System received FDA 510(k) clearance in September 2024, and is currently in limited market release, with full commercial launch planned following completion of the LMR.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRDX: